Literature DB >> 25687

Inhibition of [3H]-dihydroalprenolol binding to rat cardiac membranes of various beta-blocking agents.

P Chenieux-Guicheney, J P Dausse, P Meyer, H Schmitt.   

Abstract

Binding of [3-H]-dihydroalprenolol ([3-H]-DHA) to rat cardiac membranes was rapid and reversible (k1 = 0.633-0.701 x 10(6) M(-1) S(-1) And k(-1) = 0.0017-0.0043 s(-1). 2 [3-H]-DHA bound to a single class of binding sites with an equilibrium dissociation constant (Kd25degreesc) of 5.7+/-1.1 x 10(-9) M. 3 This binding was specific and the order of potency of adrenoceptor agonists in competing for the binding sites was (-)-isoproterenol greater than (+/-)-isoproternol greater than (+)-isoproterenol greater than (-)-adrenaline greater than (-)-noradrenaline. This was in agreement with the beta1 nature of the cardiac beta-receptors. 4 Cardioselective beta-blockers (i.e. metoprolol, acebutolol and practolol) were shown to have lower binding site affinities, when compared to other blockers. This may be related to steric hindrance by the side-chain at the aromatic end of these molecules.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25687      PMCID: PMC1668286          DOI: 10.1111/j.1476-5381.1978.tb07787.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  Binding of iodinated beta adrenergic antagonists to proteins derived from rat heart.

Authors:  T K Harden; B B Wolfe; P B Molinoff
Journal:  Mol Pharmacol       Date:  1976-01       Impact factor: 4.436

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Studies on receptor-mediated activation of adenylyl cyclases. IV. Characteristics of the adrenergic receptor coupled to myocardial adenylyl cyclase: stereospecificity for ligands and determination of apparent affinity constants for beta-blockers.

Authors:  A J Kaumann; L Birnbaumer
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

4.  Catecholamine binding to the beta-adrenergic receptor.

Authors:  R J Lefkowitz; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

5.  Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.

Authors:  E A Rosei; J J Brown; R Fraser; A F Lever; J J Morton; J I Robertson; P M Trust
Journal:  Aust N Z J Med       Date:  1976-08

6.  Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors.

Authors:  H H Harms
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

7.  Direct determination of ligand interactions with beta-adrenergic receptors on intact turkey erythrocytes: correlation of binding with biological activity.

Authors:  E M Brown; J D Gardner; G D Aurbach
Journal:  Endocrinology       Date:  1976-11       Impact factor: 4.736

  7 in total
  4 in total

1.  Comparative assessment of beta-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: similarity of inotropic and chronotropic blocking potencies against isoproterenol.

Authors:  A J Kaumann; T K McInerny; D P Gilmour; J R Blinks
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-04       Impact factor: 3.000

2.  Proceedings of the British Pharmacological Society. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

3.  Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.

Authors:  A J Kaumann; H Lemoine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

4.  Temperature related effects on the binding characteristics of beta-adrenergic receptor agonists and antagonists by rabbit lung.

Authors:  R J Altiere; J S Douglas; C N Gillis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-07       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.